Siga Technologies INC Current Assets
Siga Technologies INC (SIGA) had Current Assets of $170.38 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $170.38M.
- 2026-03-31: Assets, Current $211.53M.
- 2025-12-31: Assets, Current $212.86M.
- 2025-09-30: Assets, Current $227.75M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $170.38M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $211.53M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $212.86M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $227.75M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $229.20M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $233.62M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $231.04M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $180.69M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $176.48M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $227.89M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $238.99M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $145.97M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $134.30M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $172.53M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $185.79M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $196.90M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $153.64M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $177.11M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $208.75M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $128.94M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $127.07M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $132.89M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $143.61M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $131.10M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $105.07M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $98.02M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $180.04M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $98.62M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $121.53M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $123.54M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $121.29M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $113.66M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $122.38M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $30.93M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $37.36M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $40.89M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $58.95M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $65.17M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $69.16M 10-K · filed 2018-03-06 | |
| 2016-09-30 | $86.58M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $143.57M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $128.46M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $129.46M 10-K · filed 2017-03-07 | |
| 2015-09-30 | $139.51M 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $133.17M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $131.31M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $124.15M 10-K · filed 2016-03-04 | $129.80M 10-K · filed 2015-03-06 |
| 2014-09-30 | $124.10M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $129.73M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $133.33M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $123.94M 10-K · filed 2015-03-06 | |
| 2013-09-30 | $143.85M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $145.61M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $103.53M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $84.95M 10-K · filed 2014-03-10 | |
| 2012-09-30 | $42.54M 10-K/A · filed 2013-05-15 | |
| 2012-06-30 | $46.58M 10-K/A · filed 2013-05-15 | |
| 2012-03-31 | $46.64M 10-K/A · filed 2013-05-15 | |
| 2011-12-31 | $52.98M 10-K/A · filed 2013-05-15 | |
| 2011-09-30 | $14.54M 10-K/A · filed 2013-05-15 | |
| 2011-06-30 | $17.24M 10-K/A · filed 2013-05-15 | |
| 2011-03-31 | $20.42M 10-K/A · filed 2013-05-15 | |
| 2010-12-31 | $24.70M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |